+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell and Gene Therapy Manufacturing Quality Control (QC) Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023-2031

  • PDF Icon

    Report

  • 112 Pages
  • January 2024
  • Region: Global
  • Acute Market Reports
  • ID: 5932794
Description Jump to:
The cell and gene therapy manufacturing quality control (QC) market is expected to grow at a CAGR of 25% during the forecast period of 2024 to 2032. Cell and gene therapy manufacturing quality control (QC)plays a pivotal role in ensuring the safety, efficacy, and consistency of cell and gene therapies. The cell and gene therapy manufacturing QC market is driven by regulatory requirements, personalized medicine trends, and advancements in analytical technologies. Despite the complexity of product characterization, the market is poised for growth due to the increasing adoption of cell and gene therapies. Equipment and accessories and Process Development segments are expected to exhibit significant growth during the forecast period. Geographically, Asia-Pacific presents opportunities for expansion. Industry leaders' strategies focus on technology integration, capacity expansion, and comprehensive QC solutions to address the evolving demands of cell and gene therapy manufacturing quality control.

Stringent Regulatory Requirements

The QC market for cell and gene therapy manufacturing is driven by stringent regulatory requirements imposed by health authorities such as the FDA and EMA. Regulatory agencies demand rigorous quality control measures to ensure that cell and gene therapies meet safety and efficacy standards. For example, the FDA's guidelines for chemistry, manufacturing, and controls (CMC) emphasize thorough testing, characterization, and validation to ensure the quality and consistency of therapies. The regulatory landscape serves as a significant driver for investments in QC infrastructure and technologies.

Growing Adoption of Personalized Medicine

The rise of personalized medicine, wherein therapies are tailored to individual patients, has amplified the demand for robust QC procedures. Cell and gene therapies are often customized for each patient, requiring precise characterization, identity confirmation, and potency testing. As cell and gene therapies become more mainstream, the QC market experiences a surge in demand for advanced analytical methods and technologies to ensure therapy-specific quality and patient safety.

Advancements in Analytical Technologies

Rapid advancements in analytical technologies, such as high-throughput sequencing, mass spectrometry, and flow cytometry, have revolutionized the QC landscape. These technologies enable comprehensive characterization and analysis of cell and gene therapies, including their genetic makeup, purity, and potency. The integration of cutting-edge analytics into QC processes not only enhances the quality and reliability of therapies but also expedites development and manufacturing timelines.

Complexity of Product Characterization

A key restraint in the cell and gene therapy manufacturing QC market is the complexity of product characterization. Cell and gene therapies are often multifaceted and involve various components, making their comprehensive characterization challenging. The heterogeneity of cell populations, genetic modifications, and therapeutic mechanisms necessitates advanced analytical techniques that can accurately assess product quality. This complexity can lead to prolonged QC timelines and increased costs.

Consumables Dominate the Market by Component

 The market is segmented by component into Equipment and accessories, Consumables, and Others. In 2023, Consumables accounted for the highest revenue share, primarily due to their continuous usage in cell and gene therapy QC processes. During the forecast period from 2024 to 2032, Equipment and accessories are projected to exhibit the highest CAGR. The adoption of advanced equipment and technologies, such as next-generation sequencers and high-performance liquid chromatography systems, is expected to drive this growth.

Downstream Processes Dominate the Market by Process

The market is further segmented by process into Upstream Processes, Downstream Processes, and Process Development. In 2023, Downstream Processes generated the highest revenue, attributed to the need for purification and isolation of therapeutic cells and genetic material. However, during the forecast period, Process Development is anticipated to achieve the highest CAGR. The focus on optimizing and scaling up manufacturing processes to ensure consistent product quality is driving investments in process development and associated QC strategies.

North America Remains as the Global Leader

North America held the highest revenue share in 2023, driven by its established cell and gene therapy ecosystem, supportive regulatory environment, and significant research and development activities. However, the Asia-Pacific region is projected to witness the highest CAGR from 2024 to 2032. Increasing investments in healthcare infrastructure, rising research collaborations, and the emergence of contract manufacturing organizations (CMOs) are driving the growth of the QC market in this region.

Market Competition to Intensify during the Forecast Period

Prominent players in the cell and gene therapy manufacturing QC market include Lonza Group, Charles River Laboratories, Eurofins Scientific, WuXiAppTec, bioMérieux SA, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, QIAGEN, Merck KGaA, Intertek Group plc, Thermo Fisher Scientific, Inc., and F. Hoffmann-La Roche Ltd. These companies provide a wide array of QC services, analytical tools, and expertise tailored to the unique challenges of cell and gene therapies. Key strategies involve investing in advanced analytical technologies, expanding testing capabilities, and offering comprehensive QC solutions that support product development, manufacturing, and regulatory compliance. The market is characterized by strategic collaborations and partnerships to address evolving QC needs.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Cell And Gene Therapy Manufacturing Quality Control (QC) market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generated by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Cell And Gene Therapy Manufacturing Quality Control (QC) market and their expected impact during the forecast period.
The market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. The gowth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. The application of both top down and bottom-up approaches for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Component

  • Equipment & Accessories
  • Consumables
  • Others

Analytical Method

  • Sterility Testing
  • Purity Testing
  • Potency Testing
  • Identity Testing
  • Others (stability, viability, etc.)

Process

  • Upstream Processes
  • Downstream Processes
  • Process Development

End-User

  • Pharmaceutical & Biotechnology Companies
  • Contract Manufacturing Organizations

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key Questions Answered in This Report

  • What are the key micro and macro environmental factors that are impacting the growth of Cell And Gene Therapy Manufacturing Quality Control (QC) market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Cell And Gene Therapy Manufacturing Quality Control (QC) market?
  • Which is the largest regional market for Cell And Gene Therapy Manufacturing Quality Control (QC) market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Cell And Gene Therapy Manufacturing Quality Control (QC) market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Cell And Gene Therapy Manufacturing Quality Control (QC) market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market
2.2. Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Component, 2023 (US$ Million)
2.3. Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method, 2023 (US$ Million)
2.4. Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Process, 2023 (US$ Million)
2.5. Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By End-User, 2023 (US$ Million)
2.6. Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Geography, 2023 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2023
3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: Competitive Analysis
3.1. Market Positioning of Key Cell and Gene Therapy Manufacturing Quality Control (QC) Market Vendors
3.2. Strategies Adopted by Cell and Gene Therapy Manufacturing Quality Control (QC) Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032
4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Value, 2022-2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Volume and Pricing Analysis, 2022-2032
5.4. Market Segmentation
5.4.1. Equipment & Accessories
5.4.2. Consumables
5.4.3. Others
6. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Volume and Pricing Analysis, 2022-2032
6.4. Market Segmentation
6.4.1. Sterility Testing
6.4.2. Purity Testing
6.4.3. Potency Testing
6.4.4. Identity Testing
6.4.5. Others (stability, viability, etc.)
7. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Volume and Pricing Analysis, 2022-2032
7.4. Market Segmentation
7.4.1. Upstream Processes
7.4.2. Downstream Processes
7.4.3. Process Development
8. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2032
8.3. Volume and Pricing Analysis, 2022-2032
8.4. Market Segmentation
8.4.1. Pharmaceutical & Biotechnology Companies
8.4.2. Contract Manufacturing Organizations
9. North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
9.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
9.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
9.5. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
9.6. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
9.6.1. North America
9.6.1.1. U.S.
9.6.1.1.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
9.6.1.1.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
9.6.1.1.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
9.6.1.1.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
9.6.1.2.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
9.6.1.2.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
9.6.1.2.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
9.6.1.3.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
9.6.1.3.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
9.6.1.3.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
10. UK and European Union Cell and Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
10.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
10.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
10.5. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
10.6. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
10.6.1. UK and European Union
10.6.1.1. UK
10.6.1.1.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
10.6.1.1.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
10.6.1.1.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
10.6.1.1.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
10.6.1.2.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
10.6.1.2.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
10.6.1.2.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
10.6.1.3.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
10.6.1.3.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
10.6.1.3.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
10.6.1.4.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
10.6.1.4.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
10.6.1.4.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
10.6.1.5. France
10.6.1.5.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
10.6.1.5.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
10.6.1.5.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
10.6.1.5.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
10.6.1.6.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
10.6.1.6.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
10.6.1.6.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
11. Asia Pacific Cell and Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
11.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
11.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
11.5. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
11.6. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
11.6.1. Asia Pacific
11.6.1.1. China
11.6.1.1.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
11.6.1.1.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
11.6.1.1.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
11.6.1.1.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
11.6.1.2.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
11.6.1.2.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
11.6.1.2.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
11.6.1.3. India
11.6.1.3.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
11.6.1.3.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
11.6.1.3.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
11.6.1.3.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
11.6.1.4.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
11.6.1.4.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
11.6.1.4.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
11.6.1.5.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
11.6.1.5.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
11.6.1.5.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
11.6.1.6.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
11.6.1.6.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
11.6.1.6.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
12. Latin America Cell and Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
12.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
12.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
12.5. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
12.6. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
12.6.1. Latin America
12.6.1.1. Brazil
12.6.1.1.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
12.6.1.1.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
12.6.1.1.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
12.6.1.1.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
12.6.1.2.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
12.6.1.2.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
12.6.1.2.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
12.6.1.3.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
12.6.1.3.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
12.6.1.3.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
13. Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)
13.1. Market Overview
13.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
13.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
13.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
13.5. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
13.6. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
13.6.1. Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
13.6.1.1.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
13.6.1.1.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
13.6.1.1.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
13.6.1.2.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
13.6.1.2.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
13.6.1.2.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
13.6.1.3.2. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
13.6.1.3.3. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
13.6.1.3.4. Cell and Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
14. Company Profiles
14.1. Lonza Group
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. Charles River Laboratories
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. Eurofins Scientific
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. WuXiAppTec
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. bioMerieux SA
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
14.6. Bio-Rad Laboratories, Inc.
14.6.1. Company Overview
14.6.2. Financial Performance
14.6.3. Product Portfolio
14.6.4. Strategic Initiatives
14.7. Bio-Techne Corporation
14.7.1. Company Overview
14.7.2. Financial Performance
14.7.3. Product Portfolio
14.7.4. Strategic Initiatives
14.8. QIAGEN
14.8.1. Company Overview
14.8.2. Financial Performance
14.8.3. Product Portfolio
14.8.4. Strategic Initiatives
14.9. Merck KGaA
14.9.1. Company Overview
14.9.2. Financial Performance
14.9.3. Product Portfolio
14.9.4. Strategic Initiatives
14.10. Intertek Group plc
14.10.1. Company Overview
14.10.2. Financial Performance
14.10.3. Product Portfolio
14.10.4. Strategic Initiatives
14.11. Thermo Fisher Scientific, Inc.
14.11.1. Company Overview
14.11.2. Financial Performance
14.11.3. Product Portfolio
14.11.4. Strategic Initiatives
14.12. F. Hoffmann-La Roche Ltd.
14.12.1. Company Overview
14.12.2. Financial Performance
14.12.3. Product Portfolio
14.12.4. Strategic Initiatives
14.13. Other Notable Players
14.13.1. Company Overview
14.13.2. Financial Performance
14.13.3. Product Portfolio
14.13.4. Strategic Initiatives
List of Figures
Figure 1 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market: Quality Assurance
Figure 5 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, by Component, 2023
Figure 6 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, by Analytical Method, 2023
Figure 7 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, by Process, 2023
Figure 8 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, by End-User, 2023
Figure 9 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, by Geography, 2023
Figure 10 Market Geographical Opportunity Matrix - Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, 2023
Figure 11 Market Positioning of Key Cell and Gene Therapy Manufacturing Quality Control (QC) Market Players, 2023
Figure 12 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
Figure 13 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, by Component, 2023 Vs 2032, %
Figure 14 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, by Analytical Method, 2023 Vs 2032, %
Figure 15 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, by Process, 2023 Vs 2032, %
Figure 16 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, by End-User, 2023 Vs 2032, %
Figure 17 U.S. Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 18 Canada Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 19 Rest of North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 20 UK Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 21 Germany Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 22 Spain Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 23 Italy Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 24 France Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 25 Rest of Europe Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 26 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 27 Japan Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 28 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 29 Australia Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 30 South Korea Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 31 Rest of Asia Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 32 Brazil Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 33 Mexico Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 34 Rest of Latin America Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 35 GCC Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 36 Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
Figure 37 Rest of Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022-2032
List of Tables
Table 1 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 2 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 3 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 4 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 5 North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 6 North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 7 North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 8 North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 9 U.S. Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 10 U.S. Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 11 U.S. Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 12 U.S. Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 13 Canada Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 14 Canada Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 15 Canada Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 16 Canada Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 17 Rest of North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 18 Rest of North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 19 Rest of North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 20 Rest of North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 21 UK and European Union Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 22 UK and European Union Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 23 UK and European Union Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 24 UK and European Union Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 25 UK Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 26 UK Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 27 UK Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 28 UK Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 29 Germany Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 30 Germany Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 31 Germany Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 32 Germany Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 33 Spain Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 34 Spain Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 35 Spain Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 36 Spain Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 37 Italy Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 38 Italy Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 39 Italy Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 40 Italy Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 41 France Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 42 France Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 43 France Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 44 France Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 45 Rest of Europe Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 46 Rest of Europe Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 47 Rest of Europe Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 48 Rest of Europe Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 49 Asia Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 50 Asia Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 51 Asia Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 52 Asia Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 53 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 54 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 55 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 56 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 57 Japan Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 58 Japan Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 59 Japan Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 60 Japan Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 61 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 62 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 63 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 64 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 65 Australia Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 66 Australia Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 67 Australia Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 68 Australia Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 69 South Korea Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 70 South Korea Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 71 South Korea Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 72 South Korea Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 73 Latin America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 74 Latin America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 75 Latin America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 76 Latin America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 77 Brazil Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 78 Brazil Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 79 Brazil Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 80 Brazil Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 81 Mexico Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 82 Mexico Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 83 Mexico Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 84 Mexico Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 85 Rest of Latin America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 86 Rest of Latin America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 87 Rest of Latin America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 88 Rest of Latin America Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 89 Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 90 Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 91 Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 92 Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 93 GCC Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 94 GCC Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 95 GCC Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 96 GCC Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 97 Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 98 Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 99 Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 100 Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)
Table 101 Rest of Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Component, 2022-2032, USD (Million)
Table 102 Rest of Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Analytical Method, 2022-2032, USD (Million)
Table 103 Rest of Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market by Process, 2022-2032, USD (Million)
Table 104 Rest of Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market by End-User, 2022-2032, USD (Million)

Companies Mentioned

  • Lonza Group
  • Charles River Laboratories
  • Eurofins Scientific
  • WuXiAppTec
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • QIAGEN
  • Merck KGaA
  • Intertek Group plc
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.

Related Topics

Related Reports

Cell and Gene Therapy Manufacturing QC Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Image

Cell and Gene Therapy Manufacturing QC Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • 184 Pages
  • Global
From
Cell and Gene Therapy Supply Chain Software Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Process Component, Type of Software, Mode of Deployment, Scale of Operation, Type of End-user and Key Geographical Regions - Product Image

Cell and Gene Therapy Supply Chain Software Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Process Component, Type of Software, Mode of Deployment, Scale of Operation, Type of End-user and Key Geographical Regions

  • Report
  • 378 Pages
  • Global
From
Gene Therapy Market Report by Gene Type, Vector Type, Delivery Method, Application, and Region 2024-2032 - Product Image

Gene Therapy Market Report by Gene Type, Vector Type, Delivery Method, Application, and Region 2024-2032

  • Report
  • 136 Pages
  • Global
From
Cell & Gene Therapy Manufacturing Services Market by Type, Indication, Application, End-User - Global Forecast 2025-2030 - Product Image

Cell & Gene Therapy Manufacturing Services Market by Type, Indication, Application, End-User - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Cell and Gene Therapy CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-users and Key Geographical Regions - Product Image

Cell and Gene Therapy CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-users and Key Geographical Regions

  • Report
  • 343 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.